Table 2 Meta-analysis of the association between CDH1 -160C/A polymorphism and breast cancer risk
From: The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis
Comparisons | Odds ratio | 95 % confidence interval | P value | Heterogeneity | Effects model | |
|---|---|---|---|---|---|---|
I 2 (%) | P value | |||||
A vs C | 1.231 | 0.992–1.528 | 0.060 | 64.3 | 0.024 | Random |
AA vs CC | 1.397 | 0.922–2.116 | 0.115 | 52.5 | 0.078 | Random |
CA vs CC | 1.116 | 0.941–1.325 | 0.208 | 0.0 | 0.818 | Fixed |
CA + AA vs CC | 1.207 | 1.031–1.412 | 0.019 | 0.0 | 0.566 | Fixed |
AA vs CC + CA | 1.338 | 0.850–2.105 | 0.208 | 62.0 | 0.032 | Random |